Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing

被引:2
|
作者
Yi, Tong
Bai, Rui
Sun, Hairui
Lan, Feng
Zhang, Hongjia
He, Yihua
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Beijing Key Lab Maternal Fetal Med & Fetal Heart, Beijing, Peoples R China
[2] Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Lab Cardiovasc Precis Med, Beijing, Peoples R China
[3] Capital Med Univ, Anzhen Hosp, Collaborat Innovat Ctr Cardiovasc Disorders, Beijing 100029, Peoples R China
基金
国家重点研发计划;
关键词
D O I
10.1016/j.scr.2020.101893
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The non-POU domain containing octamer-binding gene (NONO) encodes a member of a small family of RNA-binding and DNA-binding proteins, whose variants can cause intellectual disability and congenital heart defects. In this study, we generated a homozygous NONO knockout (NONO-KO) induced pluripotent stem cell (iPSC) line (CMUi002-A-1) using the CRISPR/Cas9-based genome editing system. The gene-edited line had a normal karyotype, expressed pluripotency markers, and was able to differentiate into all three germ layers in vivo. This cell line will provide a platform to study the pathogenic mechanisms of noncompaction cardiomyopathy and neurocyte dysfunction related to NONO mutations.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Generation of an S100B homozygous knockout pluripotent stem cell line (WAe009-A-94) by the CRISPR/Cas9 system
    Zhang, Pengxia
    Wang, Hongyue
    Li, Shengzhen
    Guo, Tianwei
    Zhang, Rui
    Zhou, Ping
    Ding, Shaoli
    STEM CELL RESEARCH, 2022, 64
  • [32] Generation of a homozygous and a heterozygous SNCA gene knockout human-induced pluripotent stem cell line by CRISPR/Cas9 mediated allele-specific tuning of SNCA expression
    Schneider, Yanni
    Turan, Soeren
    Koller, Aron
    Krumbiegel, Mandy
    Farrell, Michaela
    Plotz, Sonja
    Winkler, Juergen
    Xiang, Wei
    STEM CELL RESEARCH, 2022, 65
  • [33] Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9
    Ratnavadivel, Sandra
    Dammeier, Joline
    Gaertner, Anna
    de Toledo, Marcelo A. Szymanski
    Zenke, Martin
    Gummert, Jan
    Rasmussen, Torsten Bloch
    Klinke, Nora
    Juergens, Kai
    Meyer, Heiko
    Paululat, Achim
    Milting, Hendrik
    STEM CELL RESEARCH, 2024, 76
  • [34] Generation of a homozygous S100A1 knockout human embryonic stem cell line (WAe009-A-73) by the CRISPR/Cas9 editing system
    Zhang, Shuai
    Guo, Tianwei
    Song, Yuanxiu
    Jiang, Mengqi
    Jiang, Youxu
    Dong, Tao
    Zhang, Siyao
    Wang, Hong
    Hou, Xiaotong
    STEM CELL RESEARCH, 2022, 59
  • [35] Generation of a TBX5 homozygous knockout embryonic stem cell line (WAe009-A-45) by CRISPR/Cas9 genome editing
    Zhao, Tiantian
    Bai, Rui
    Wu, Fujian
    Lu, Wen-Jing
    Zhang, Jun
    STEM CELL RESEARCH, 2021, 51
  • [36] Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
    Ben Jehuda, Ronen
    Shemer, Yuval
    Binah, Ofer
    STEM CELL REVIEWS AND REPORTS, 2018, 14 (03) : 323 - 336
  • [37] Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
    Ronen Ben Jehuda
    Yuval Shemer
    Ofer Binah
    Stem Cell Reviews and Reports, 2018, 14 : 323 - 336
  • [38] Generation of a MCPH1 knockout human embryonic stem cell line by CRISPR/Cas9 technology
    Wang, Zerui
    Cui, Yazhou
    Shan, Yongli
    Kang, Baoqiang
    Shi, Liang
    Geng, Kaiyue
    Han, Jinxiang
    STEM CELL RESEARCH, 2020, 49
  • [39] Generation of a TRPV1 knockout human pluripotent stem cell line (WAe009-A-U) using CRISPR/Cas9
    Cao, Yuhong
    Tang, Ling
    Su, Jun
    Wang, Hao
    Liang, Ping
    Rong, Kuang
    Gong, Tingyu
    STEM CELL RESEARCH, 2023, 72
  • [40] Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9
    Yumlu, Saniye
    Stumm, Juergen
    Bashir, Sanum
    Dreyer, Anne-Kathrin
    Lisowski, Pawel
    Danner, Eric
    Kuehn, Ralf
    METHODS, 2017, 121 : 29 - 44